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 This paper seeks to understand how social media can be employed by 
pharmaceutical brands as an integral component of the marketing mix. Novo Nordisk will 
be used as an example to demonstrate the unsuccessful use of social media marketing. 
Similarly, Johnson & Johnson, Sanofi-Aventis and Bayer Didget will be used as 
examples to demonstrate the successful use of social media marketing. The framework 
necessary in the construction of a successful social media marketing campaign will be 
discussed, with each component receiving individual attention. This framework will be 
implemented in a hypothetical campaign for the pharmaceutical brand, Vytorin, to 
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The pharmaceutical industry is one of the most lucrative industries in the United 
States, and one that has experienced significant change over the past five years. This 
change however, has had little to do with the research and production of pharmaceuticals, 
and instead more to do with how pharmaceutical companies market their products.   
Traditionally, pharmaceutical companies directly targeted doctors and healthcare 
providers with regard to their strategic marketing. These companies would “detail” 
doctors, with the average family doctor receiving 28 visits per week from pharmaceutical 
representatives.1 During such visits, representatives would provide doctors with free 
information on all of their brands latest drugs and healthcare devices. With this practice, 
pharmaceutical companies spent approximately 86% of their budget marketing to doctors 
and healthcare providers each year.1 This entailed spending an average of $8, 290 per 
doctor per year. In contrast, these companies would spend only 14% of their budget 
marketing directly to consumers.1 This approach, however, appears to be changing 
rapidly. With the “re-branding” of pharmaceuticals and diseases alike, patients are 
evolving into consumers at a fast pace.  
The re-branding of Eli Lilly’s top selling anti-depressant Prozac, as Sarafem, 
serves as a good example. Mary Ebeling, a contributor on PR Watch, observes the re-
branding of Prozac in her article “Beyond Advertising: The Pharmaceutical Industry’s 
Hidden Marketing Tactics.” Ebeling states that Prozac and Sarafem are chemically 
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identical, and that the only differences between the two drugs are branding and what each 
is prescribed for.1 Prozac is used to treat the symptoms of depression, whilst Sarafem is 
used to treat the symptoms of premenstrual dysphoric disorder.1 In her article, Ebeling 
describes how this came to be, “By going back to the FDA and getting approval to use 
Prozac to treat a new set of symptoms, Eli Lilly won big. The company now has two 
separate markets to sell to, and it stymied potential generic competitors to boot.”1 
 Albeit, ethically questionable, the rebranding of such drugs is proving to be a 
highly effective marketing strategy for pharmaceutical companies.1 Consumers see and 
hear very little about the rebranding of pharmaceutical products and for the most part are 
oblivious to the process. With regard to this, Ebeling writes, "insidious marketing 
campaigns seeking to rebrand medical conditions as lifestyle choices, and the patients 
who suffer from them as consumers, have received little scrutiny.”1 Consequently, the 
door is left open for pharmaceutical giants to market their products directly to consumers, 
totally bypassing doctors and healthcare specialists. With new horizons in sight, these 
companies have naturally been seeking out new ways to do so.  
 
In light of this, it is evident that social media would provide the necessary tools 
for pharmaceutical companies to market their products directly to consumers. There are 
numerous reasons as to why pharmaceutical companies should employ social media as a 
legitimate component of their marketing strategies. The most important reason however, 
is that today’s consumer expects companies to have a presence in social media. 
According to a 2008 study by Cone, 60% of Americans use social media, and of those 
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surveyed, 59% interact with companies using social media websites.2 Furthermore, 93% 
of social media users believe a company should have a presence in social media. 
Moreover, 85% of social media users believe that companies should not only have a 
presence in social media, but that there should be interaction between these two parties. It 
is therefore possible to infer that consumers are not only open to communicating with 
brands online, but they would prefer to. As a result, companies that fail to interact with 
their consumer base through social media are failing to meet the expectations of 
consumers. According to Mike Hollywood, Director of New Media for Cone, “the news 
here is that Americans are eager to deepen their brand relationships through social media 
…it isn’t an intrusion into their lives, but rather a welcome channel for discussion.”2 
 
Further to this, there has been a dramatic shift in the approach consumers take 
with regard to healthcare. Traditionally, healthcare information has only been accessible 
through healthcare professionals and medical books, both of which often carry large price 
tags. However, the Internet has made medical information far more accessible to 
consumers, irrespective of their location, income or age. Today, 80% of Internet 
consumers search online for health information, trusting peer-generated social media 
content more than their physicians, and pharmaceutical company websites.3 This is a 
trend that pharmaceutical companies can no longer afford to ignore. In order for brands to 
                                                
2 "Cone Finds that Americans Expect Companies to Have a Presence in Social Media." 
Editorial.Cone. N.p., 2009. Web. 10 Nov. 2009.  
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engage consumers effectively, they must have an online presence beyond a typical 
product information website.  
According to Michael Maher, a contributor on Adotas, an interactive advertising 
blog, marketing via social media can make pharmaceutical marketing a great deal more 
effective. In his article “Pharma Companies and Social Media Marketing,” Maher 
explains the concept behind this, stating that social media marketing creates better 
informed patients, who will make smarter choices, become more compliant, and advocate 
an effective treatment to their social contacts.3 Nonetheless, many pharmaceutical 
companies fear laws and regulations enforced by the FDA, and question if it is even 
possible to engage consumers via social media marketing without serious consequences. 
What many companies have failed to realize however, is that these laws and regulations 
do not restrict the channel of communication that pharmaceutical companies may use, 
simply the message. Maher comments on this issue in his article, stating, “the common 
belief is that there are too many regulatory hurdles around reporting adverse 
events…While it certainly isn’t as simple for pharma as it is for CPG, technology or 
entertainment marketers, many drug companies are beginning to use social media very 
effectively and there are easy ways to get started, requiring only small modifications to 
current regulatory processes.”3  
Therefore, as the number of pharmaceutical companies choosing to employ social 
media marketing continues to increase, the ones that do not will be left behind, out of 
touch with consumers. Among the companies already employing social media in their 
marketing strategies are Johnson & Johnson with J&J BTW, Sanofi-Aventis with Sanofi-
Aventis.TV, and Bayer Diabetes Care with Bayer Didget. These companies are to serve 
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as examples of successful social media campaigns for the purpose of this study. There 
are, however, companies whose social media efforts have failed to achieve the desired 
outcome; Novo Nordisk and the Charlie Kimball Twitter account will serve as an 





The Unsuccessful Campaign 
Novo Nordisk 
 
In 2009, Novo Nordisk announced the official launch of its Race with Insulin 
Twitter page. This effort was the latest development in the company’s 2009 partnership 
with Firestone Indy Lights racecar driver, and diabetic, Charlie Kimball. According to a 
press release on Kimball’s official website, “the first American open-wheeled racing 
driver with diabetes will provide updates called ‘tweets’ directly from his computer or 
mobile phone about his race progress and diabetes management, representing a different 
direction in sharing real patient experiences.”4 Commenting on his involvement with 
Novo Nordisk, Kimball writes on the same website, "When I am not traveling at speeds 
of 160 miles per hour, I hope to reach as many people living with diabetes as possible 
with my own story and inspire them to take an active role in managing their health."4 
The Campaign 
Upon observation of Race with Insulin, it appears that Kimball has stayed true to his 
word, with multiple daily Tweets tracking his life. For example: 
 




                                                




This appears to be a smart move for Novo Nordisk; Kimball, an inspirational figure, is 
sharing personal experiences of not only life as a world-class racecar driver, but also of 
life with diabetes. By sponsoring such efforts, Novo Nordisk conveys the message that it 
cares deeply about the daily struggles of its consumers, and of all those living with 
diabetes. However, many of Kimball’s Tweets also make reference to Levemir and 
NovoLog, Novo Nordisk’s prescription medications, which questions the legitimacy of 
such Tweets. If a single Tweet appears to have been manipulated by the brand’s 
marketing team, it suggests that the rest may also be inauthentic. For example:  
 
 
Fig. 2 - Racewithinsulin. Online posting. Twitter. Novo Nordisk, 2009. Web. 11 Nov. 2009.        
<http://twitter.com/racewithinsulin>. 
 
This Tweet, in addition to many others, elicited suspicious responses from not 
only Kimball followers, but from pharmaceutical marketing experts, too. John Mack, 
author of Pharma Marketing Blog writes, “The Levemir Tweet, to me, just seems like a 
sleazy way of…mentioning the product name! It’s not enough that the name is all over 
Kimball’s race suit and car, he also has to mention it every once in a while in his 
Tweets?”5 By marketing its products in such a way, Novo Nordisk give the impression 
that it has a subversive agenda.  
 
                                                
5 Mack, John. "Novo Nordisk Selectively Copies & Edits Kimball's Tweets." Pharma 
Marketing Blog. N.p., 22 June 2009. Web. 11 Nov. 2009.  
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Nevertheless, upon first glance of Race with Insulin, Kimball’s tweets appear 
authentic, with short anecdotal updates of his daily life. It also appears that Kimball’s 
sporadic name-dropping of Novo Nordisk prescription medications is his only warranted 
criticism. However, with very little research, it is easy to discover that Kimball has a 
second Twitter account, Charlie Kimball. Upon comparison of the two pages, patterns are 
instantly detectable. There is an almost one-to-one mapping of Tweets between the two 
accounts, with only subtle differences:  
 
@charliekimball: “Finished 7th. Made contact with Pippa Mann halfway through 
after she was a lap or two off the lead. Happy with the result and the points!”6 
 
Becomes: 
@racewithinsulin: “Finished 7th. Very pleased with the result. It was great racing 
under the lights! Headed back home to California tomorrow.”7 
  
Mack, also observing this pattern wrote, “It appears that someone is selecting a sample of 
Charlie’s authentic tweets made @charliekimball, editing them, and adding branded 
messages to them when necessary. Is this any way for a pharma brand to carry on an 
authentic conversation?”5 
 
                                                
6 "charliekimball." Twitter. N.p., 2009. Web. 11 Nov. 2009.  
 





 In asking this question, Mack has honed in on the underlying issue here. It is not 
that Kimball has multiple Twitter accounts; many users of social media maintain multiple 
accounts as a means of communicating more directly with different groups of people. The 
issue also has little to do with Kimball’s Levemir endorsing posts. As a Novo Nordisk 
sponsored page, this is to be expected. The fundamental issue here is dishonesty. 
Followers of Race with Insulin do so with the expectation that they are receiving 
authentic updates of a person’s life, and more importantly, how this person deals with 
diabetes on a daily basis. Commenting further, Mack writes, “Charlie Kimball’s Tweets 
would be much more interesting if he stopped posting about cleaning his race suit, taking 
Levemir, etc, and told us a little bit about how he FEELS being a race car driver with 
Diabetes, how he deals with the unique problems his medical condition gives 
him…THAT would be truly inspirational!”5 
 
Novo Nordisk has misunderstood the purpose of social media in this context. The 
real challenge for pharmaceutical companies is to make personal connections with 
consumers via social media, as opposed to finding new ways to advertise products.5 
Using new media, Novo Nordisk has an opportunity to develop relationships with 
consumers, as well as observe and learn from their individual experiences. In a well-
nurtured environment, Novo Nordisk could potentially create a community where people 
have shared interests and concerns. Central to this however, is trust, the key component 
Novo Nordisk have overlooked. By building trust with consumers in an authentic, non-
marketing manner, Novo Nordisk could raise consumer awareness of its brand as a caring 
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and worthwhile entity. As a result, interest in the brand’s products would have the 




Successful Social Media Campaigns 
Johnson & Johnson 
 
In 2007, Johnson & Johnson launched the second phase of its Web 2.0 strategy, 
J&J BTW: a three dimensional view of Johnson & Johnson, a corporate blog authored by 
Marc Monseau, Director of Corporate Communications for Social Media at J&J. The 
blog promises to be a voice for the company, conveying this message to its viewers, “I 
will try and find a voice that gets lost in formal communications… We’re going to do 
what we can to talk openly, directly and to the best of our knowledge.”8 With regards to 
why J&J have chosen to embark on this venture, Monseau says the following, “Everyone 
else is talking about our company, so why can’t we?”8 Here, it is possible to note that J&J 
have chosen to be proactive, as opposed to reactive, with regards to its brand image in the 
realm of social media. In a recent interview, Monseau spoke about J&J BTW, and how it 
came to be, stating: 
About two and a half years ago, we recognized that there was this growing 
influence of the blogosphere and the lack of trust and credibility, and more stilled, 
carefully framed messages coming from companies, institutions and 
organizations. We realized that we needed to one, understand this space a little 
better and two, try to get some experience with joining in some of the 
                                                




conversations that we knew were taking place about our company and our 
products online.9 
In stating this, Monseau has to some extent communicated what users’ 
expectations for the blog should be; J&J simply want to join in the ongoing conversations 
about its brand and products. Whether J&J anticipated the moderation of these 
conversations is unknown, but knowing what the company’s intentions were makes it 
possible to better judge its performance.  
The Campaign 
J&J BTW is essentially a collection of articles ranging in topic from disease 
specific content and company news to human-interest stories and industry developments. 
The latest entries, for example, include “Language shouldn’t be a barrier to Diabetes 
education,” followed by “Distracted drivers in school zones as dangerous as drunk 
drivers.” This content corresponds to a description, penned by Monseau, on the blog 
describing what the site would provide for its users, “On J&J, there will be talk about J&J 
– what we’re doing, how we’re doing it and why. There will be comment on the news 
about our company and the industry.”8 
To the right of the entries is a large content list, allowing users to find previous 
entries according to specific categories. Some of these categories include “Blood 
Donation,” “Childhood Safety,” “Health 2.0,” “Medical Trials,” “Health Coverage,” 
“Mommy Vloggers” and “Health and Wellness.” In addition to this, users are able to 
                                                
9 Senak, Mark. "J&J and Social Media - How'd They Do It? A Conversation with J&J." 




comment on entries and a small tab informs users as to how many comments there 
currently are. There is an RSS Feed, as well as individual feeds for posting entries to four 
of the largest social networking sites; del.ico.us, Digg, Facebook and Twitter. This allows 
users to share J&J stories with consumers who are not active users of J&J BTW, creating 
awareness of the site. In addition to this, the blog contains an easily accessible archive of 
past entries, providing users with an extensive library for their preferred topics. The blog 
also boasts a blogroll, listing useful sources related to health and the pharmaceutical 
industry, most of which are unrelated to J&J.  
 
Fig. 3 - Monseau, Marc. "ABOUT JNJ BTW." JNJ BTW. N.p., 2009. Web. 10 Nov. 2009. 
<http://jnjbtw.com/about-jnj-btw/>. 
 
Further to this, the blog has an interactive list of J&J’s other social media tools. 
The site features a J&J Twitter feed; a J&J Facebook link, allowing users to join the fan 
club; a link to Kilmer House, J&J’s first blog that documents the story behind the 
company and its people; and a space for J&J’s Health Channel on YouTube with a video 
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that users can instantly play. The video currently displayed is “Living with Crohns 
Disease.”  
Success 
There are two ways to measure the success of J&J BTW, using either quantitative 
or qualitative information. However, quantitative data in this case is scarce, with only the 
number of entry comments pertaining to the success of the blog. Therefore, it is necessary 
to rely heavily upon secondary data, such as trade press and consumer blogs, to determine 
the success of J&J BTW. Entry comments will also be viewed in order to establish 
consumer response to the blog.  
With regard to user comments on J&J BTW, the majority of posts have received 
at least one, with some entries receiving as many as twenty. The example below, an entry 
titled, “So what’s with the new look?” includes thirteen comments.  
 





Although thirteen comments may not appear that large a number when compared 
to the number of comments on larger blogs or social networking sites, this is a significant 
feat for J&J.  As a brand-specific pharmaceutical blog, J&J BTW should naturally expect 
less traffic than other, more general blogs or social media vehicles. Nonetheless, these 13 
comments are sufficient enough for J&J BTW to establish a community, which will 
inevitably lead to an increase in user comments in the future. In addition to this, JD 
Lasica reported in his recent presentation “Social media: opportunities for pharma,” that 
since 2007 there have been hundreds of reader comments on J&J BTW, with zero 
reported adverse events.10 Furthermore, by allowing users to share the articles beyond 
J&J BTW, J&J are helping to generate more extensive conversations on social networks 
that are already established and highly active. 
With regard to secondary data, J&J BTW has received a significant amount of 
attention from both the advertising and pharmaceutical industries, as well as consumers. 
Not only has the blog received recognition, it has been praised for a variety of reasons. 
According to Ron Ploof, author of the new e-book Johnson & Johnson Does New Media: 
Lessons from a 123 year old, $64 Billion New Media Innovator, J&J has achieved what it 
intended with J&J BTW. In his book, Ploof writes, “JNJ has become what it set out to be, 
a place where the company can join the online conversation about a subject that it knows 
lots about..Johnson & Johnson.”11 This highlights the importance of J&J outlining its 
                                                
10 Lasica, JD. "Social media: opportunities for pharma." slideshare. N.p., Oct. 2009. 
Web. 10 Nov. 2009.  
 
11 Ploof, Ron. Johnson & Johnson Does New Media: Lessons from a 123 year old, $64 
Billion New Media Innovator . N.p., 15 June 2009. Web. 10 Nov. 2009. 
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intentions with regard to the blog, and how it has provided critics with very little room to 
criticize the site. 
 Ploof also comments on various functions of J&J BTW. With regard to the site’s 
blogroll (which lists sources unrelated to J&J), Ploof commends J&J for appearing to put 
users before company gain. He suggests that J&J is simply taking a page out of its history 
of public education by linking to other blogs that also share information about health and 
human welfare.11 This is where J&J has succeeded tremendously. By placing the wants 
and needs of consumers ahead of company gain, J&J presents itself as caring and selfless 
brand. Not only is this important given the nature of J&J products, but it also builds a 
high degree of trust with consumers.  
J&J BTW has also been praised for its transparency and tone. An entry on 
pharmaceutical blog Eye on FDA, “J&J and Social Media - How'd They Do It? A 
Conversation with J&J,” received a user comment that said the following, “JNJ BTW 
helps them appear to be more transparent than your traditional Pharma brand…I work for 
a Pharma advertising agency and I wish more companies could appreciate that bravery 
here can result in important benefits to the company's overall brand.”9 Not only is J&J 
being commended for its social media strategy, the company has also been recognized for 
its willingness to push forward and tread new ground. This is important as it portrays J&J 
as an innovative company, complementing its brand image.   
Commenting on the tone of J&J BTW is Deborah Dick-Rath, author of Changing, 
an article about social media, and new marketing for pharmaceutical companies and 
healthcare providers. She writes, “Although J&J BTW is full of corporate and industry 
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information, it tries to maintain a voice rather than lapsing into “corporate speak.” This 
helps create a feeling of trust among its readers.”12 Again, J&J is commended for its 
efforts toward building relationships and trust with consumers, something that is often 
difficult to achieve in the pharmaceutical industry. By communicating with consumers 
openly, without hiding behind industry jargon and marketing ploys, J&J have been able 
to start an honest dialogue, which was one of the company’s initial objectives.  
J&J BTW has also been used for additional purposes by J&J, tackling some of the 
more urgent communication problems that the company encounters. In response to a J&J 
marketing effort gone wrong, Kathy Widmer, Vice President of marketing for McNeil 
Consumer Healthcare, used the blog to apologize to those offended by a tongue-in-cheek 
marketing effort called “Motrin Moms.”11 According to Ploof, who makes several 
references to the occurrence, “Widmer’s blogpost addressed the problem head on, made 
no excuses, and detailed a step-by-step plan for how the company would rectify the 
situation.”11 This denotes the usefulness of J&J BTW to communicate with consumers 
instantly about anything it so wishes. It also demonstrates how J&J are using honesty and 
accountability as ways to further build trust with its consumers.  
Fundamentally however, who better to ask than Monseau himself about the 
success of J&J BTW. In a recent interview, Monseau commented on what both he and 
J&J have been able to learn as a result of the blog. He states that the blog has allowed 
him to learn a great deal about J&J’s consumers, as well as the company’s own voice. 
Monseau also notes that there have been unexpected benefits to blogging, with new 
relationships emerging, and the evolution of new learning.12 J&J BTW has enabled J&J to 
                                                
12 Dick-Rath, Deborah. Changing. N.p., Aug. 2008. Web. 10 Nov. 2009.  
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build relationships with consumers that the company may not have otherwise been able to 
reach. This has provided the company with new insight into the feelings and opinions of 






















In May 2009, Sanofi-Aventis launched Sanofi-Aventis.TV, an interactive video 
news website. The site is part of a new global strategy to increase transparency and 
understanding of the pharmaceutical company’s operations. The site is an extension of 
the central Sanofi-Aventis website, as well as part of a companywide initiative to 
transform Sanofi-Aventis into a global healthcare leader.13 Geoffroy Bessaud, Senior 
Director for Sanofi-Aventis media relations and corporate communications commented 
on the company’s new global strategy, stating, “We are setting up new tools for 
communicating, either within the company or outside of the company.”13 Sanofi-
Aventis.TV is the latest and most significant of these new communication tools, with six 
themed channels to reach the company’s different audiences, which includes patients, 
healthcare professionals, employees, shareholders and the media. According to Bessaud, 
“We really want to open a window into the group and we want to start a dialogue with 
our many audiences. We want to provide prospective on the company’s missions as well 
as on strategic directions.”13 
The Campaign 
The first channel, “Spotlight”, provides content regarding the company’s current 
position, its goals and ongoing developments – or rather, all things business related. 
Some of the videos include “The New Strategy,” “The Main Strengths of Pharmaceutical 
Operations” and “Sanofi-Aventis R&D: Next Steps.” On the second channel, “Our 
Expertise,” users can learn about research and development of Sanofi-Aventis 
                                                
13 Lee, Jaimy. "Sanofi-Aventis launches global video news site ." PR Week. N.p., 21 May 
2009. Web. 10 Nov. 2009.  
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pharmaceuticals, as well as some of the manufacturing processes. Some of the videos 
include “The Medicine: From its discovery to its launch to the market” and “Safety of 
Persons and Property.” This particular channel also provides content regarding 









The third channel, “Around the World,” provides country specific content, such as 
“Sanofi-Aventis in Italy” and “Sanofi-Aventis in Ghana.” This channel also includes 
various videos providing a global overview of healthcare issues and current epidemics. 
Here, users can also find videos specific to Sanofi-Aventis’ individual response to global 
illnesses, for example, “Epidemik: An infectious exhibition.” The fourth channel, “Your 
Health,” consists of six sub-channels. These include “First Aid Actions,” “Infectious 
Diseases,” “Rhythm Disorders,” “Cancers,” “Vaccines” and “Lifestyle.” Amongst these 
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channels, users can find a vast assortment of videos from “Dengue Fever: an under-
diagnosed disease” to “Sanofi-Pasteur: create vaccines to protect human life.” The 
“Lifestyle” sub-channel provides the most content with videos from weight loss and 
phobias to self-examinations and fitness. These include, but are not limited to, “Listening 
to your body: Tai Chi” and “Back pain? The right position to move.” 
 
The fifth channel, “Solidarity,” focuses on social responsibility and Sanofi-
Aventis’ humanitarian efforts. Videos include “Fight Cancer in Honduras and Tanzania,” 
and “TB Free: fight Tuberculosis.” The sixth and last channel, “Working for the People,” 
provides a mixture of ethics, general issues surrounding the pharmaceutical industry, as 
well as social responsibility regarding healthcare on a global scale. Videos include titles 
such as “Our children Matter,” “Counterfeiting: a danger to public health,” and 
“Handicap: listen to them.” 
 
In addition to these six channels, Sanofi-Aventis.TV boasts a number of useful 
Web 2.0 elements; the site allows users to share and vote for videos they like, as well as 
sign up to the RSS channel feeds. Although the site does not yet offer users the option to 
comment on videos, or upload their own, the site does encourage users to e-mail their 
expectations of the site to the company. In its current state, Sanofi-Aventis.TV is updated 





Fig. 6 - Sanofi-aventis.tv. Sanofi-Aventis, 2009. Web. 14 Nov. 2009. 
  <http://www.sanofi-aventis.tv/home/index.php>. 
 
Success 
It can be very difficult to determine the success or overarching impact of an 
online resource such as Sanofi-Aventis.TV. However, according to one online source, 
Sanofi-Aventis.TV receives an estimated 653 visits per day. There are also 438 Google 
links that either mention Sanofi-Avetis.TV or contain links directly to it.14 However, 
although this information is useful, it is not necessarily the best way to measure the 
success of Sanofi-Aventis.TV. In this particular instance, observing trade press, as well as 
online commentary and critique is the most effective method of measuring the website’s 
success. By doing so it is possible to gage how well Sanofi-Aventis.TV has been received 
by consumers, the pharmaceutical industry, and marketing professionals alike. It also 
provides some indication as to the website’s future growth.  
                                                
14 statbrain. N.p., 2008. Web. 10 Nov. 2009.  
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Upon review of many online sources, it is evident that Sanofi-Aventis.TV has 
been universally well received. Making headlines on several leading pharmaceutical and 
marketing publications, Sanofi-Aventis.TV has been praised for many of its components 
ranging from its original content and diverse reach, to its transparency and honest 
approach to healthcare marketing. Sanofi-Aventis.TV has been repeatedly praised for 
“thinking outside the box” and creating a platform that offers more than many other 
social media sites that simply allow users to communicate with one another. Echoing this 
is an entry on Beaker’s Blog, a blog about the life sciences industry, which reads, “while 
other leading companies are just experimenting with Twitter, blogging and other forms of 
social media, Sanofi-Aventis has officially raised the stakes by taking their online 
presence to another level.”15 By staying ahead of the competition, Sanofi-Aventis has 
been able to portray their brand as innovative and cutting-edge – desirable qualities in the 
pharmaceutical industry.  
In addition to this, Sanofi-Aventis.TV has been praised for its varied and original 
content, as well as its attempt to attract diverse audiences. An entry on Med 2.0, a blog 
dedicated to pharmaceutical marketing, reads, “…they haven’t just focused on a single 
topic, such as patient testimonials, brand promotion, corporate 
announcements/interviews, recruiting videos, etc. But instead, they chose to associate 
their overall corporate brand with all of these types of information.”16 In doing so, Sanofi-
Aventis has been able to broaden its appeal, moving the company one step closer to 
                                                
15 "Bienvenue Sanofi-Aventis.tv." Beaker's Blog. Vistek, 30 May 2009. Web. 10 Nov. 
2009.  
 
16 Shwen. "GSK Launches Corporate Blog and Sanofi Launches Sanofi-Aventis TV ."  
med 2.0. N.p., 16 June 2009. Web. 10 Nov. 2009.  
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becoming a global healthcare brand. Moreover, the nature of the videos is such that it 
allows Sanofi-Aventis to convey its core values in a humanistic manner, portraying the 
brand as a caring entity. Praising Sanofi-Aventis for its fresh attempt to convey company 
values is Daniel Ghinn, a contributor on Creative Interactive, who says “It’s not news; 
you would not expect to see a press release about the everyday experience of the 
company’s workforce. But it communicates powerful messages about Sanofi-Aventis’ 
values. Words like ‘make a difference,’  ‘the lives of others,’ ‘listener,’ ‘communicate,’ 
‘respect,’ ‘dignity,’ ‘ethical,’ ‘responsibilities,’ are all captured in (an employers) 
words.”17 Here, Ghinn describes the purpose of Sanofi-Aventis.TV, exactly what it is and 
is not supposed to be. He also observes how the words of employees and patients 
contribute to shaping the brand’s image. The site provides more than news updates on 
company developments; it is supposed to provide real insight into the processes and 
people that represent Sanofi-Aventis’ core values. 
With regard to audience participation, Ghinn also had the following to say, 
“Described by Sanofi-Aventis as ‘A window on our company,’ the format is certainly 
likely to engage a much broader range of stakeholders than traditional pharmaceutical 
communications and press releases.”17 Evidently, this has been a smart move for Sanofi-
Aventis; by appealing to all of its audiences through one medium, the company gives the 
impression that it cares equally about these groups, as the quality of content provided for 
patients is the same as the content provided for healthcare professionals.  
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Sanofi-Aventis.TV has also been praised most notably for the transparency of its 
website and its efforts to increase understanding of the company’s operations across the 
world. Again reporting on Sanofi-Aventis.TV is Med 2.0, with an entry that reads,  “I 
think SA.TV is a way for the public to get a better understanding of what Sanofi-Aventis 
is all about and the wide array of activities that drug companies — like Sanofi — are 
involved with. It’s like a ‘behind the scenes’ documentary that provides a different 
perspective to what is being portrayed and perceived publicly.”16 This strategy has 
undoubtedly been successful for Sanofi-Aventis.  By adopting such transparency, Sanofi-
Aventis is able to literally show audiences exactly what it is involved in, how many 
projects it is running simultaneously, as well as the progression of these projects over 
time. This is also the most effective way for the company to illustrate the sheer size of its 
operations. Similarly, by adopting a sense of openness, the company is able to create 
relationships and build trust with both consumers and observers alike, which will have a 






In July 2009 Bayer Diabetes Care (UK & Ireland) released the first and only 
blood glucose meter specifically designed for the needs of children suffering from Type 1 
diabetes. Intended for children aged five to 14, the device connects directly to Nintendo 
DS and Nintendo Lite Gaming Systems. According to the Bayer Didget Official Website, 
Paul Wessel, the parent of a child with Type 1 diabetes, initially developed the Didget. 
Whilst working as Director of Marketing for Banner Engineering, Wessel became 
concerned with the control of his son’s diabetes, a condition requiring several glucose 
measurements per day. Under “Product Information,” the site reads, “Paul noticed that 
although his son Luke was constantly losing his blood glucose meter, he could always 
find his Nintendo™ Game Boy.”18 Wessel believed that in this day and age, there had to 
be a way for his son to test his blood glucose in a fun and non-threatening manner. In an 
interview, Wessel was reported to have said, “Why not combine the two devices into 
one?”19 As a result, the Bayer Didget was developed, and Wessel became Sr. Director of 
New Product Development for Bayer HealthCare Diabetes Care.  
The Campaign 
The Bayer Didget is modeled off of Bayer’s Contour Meter and features a sleek 
design that some have described as reminiscent of the Apple iPod.19 According to the 
Bayer Didget Website, the Didget converts test results into rewards points that children 
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can use to unlock new game levels and buy in-game items. The system includes “Knock 
‘Em Down: Worlds Fair” Video Game Arcade for use with the Nintendo DS and DS Lite. 
The Didget rewards system is intended to encourage consistent testing, and assist in the 
development of effective diabetes management. Additional bonus points may also be 
earned when children consistently test their blood glucose three times a day, everyday for 
at least one week and up to ninety days.  
The device also has customizable settings, offering users two different modes, 
“Basic” and “Advanced,” for children to grow into.18 The “Basic” mode offers “Fast 5-
second test time,” “14-day average,” “7-day HI/LO Summary” and “480 test result 
memory.” The “Advanced” mode offers all of these elements, in addition to the 
following; easy personalization of HI/LO blood glucose target range setting; HI/LO test 
result summary that shows tests above and below your child’s glucose target level; pre- 
and post-meal markers that help children quickly identify tests taken before and after 
eating; selectable post-meal reminders that can help children remember to test after meals 
at a time that works for their routine; and seven-, 14- and 30-day averages. 
 In addition to the games, the system also boasts an online social network, Bayer 
Didget World, designed solely for Didget users. This password protected site is intended 
to be a web community where Didget users can further redeem their points by 
customizing their page and unlocking mini-games. Once Didget users have registered 
with Bayer Didget World, they are invited to join Bayer Around U support program. 
Some of the benefits include access to Bayer Diabetes Support, staffed by qualified 
nurses; free record diaries, batteries and quality control solutions for life; a range of 
 
28 
information about living with diabetes; and choice of free, funky stickers to customize 
one’s meter and slide cover.20  
 
     Fig. 7 - Bayer Didget. Bayer Health Care, 2009. Web. 10 Nov. 2009. 
     <http://www.bayerdidget.co.uk/About-Didget/Product-Information>. 
 
Success 
One of the most important aspects of the Bayer Didget is the story of its origins, 
which has been used extensively in the promotion of the device. The Bayer Didget was 
initially designed by a parent, the father of a child suffering with Type 1 diabetes, whose 
intentions are therefore, automatically regarded as positive. This gives parents something 
that they can relate to, making the device more appealing. The story also provides users 
and observers with a caring image of the Bayer Didget system, whereby the people 
behind it are more concerned with its consumers health and well being than with sales. 
As this is stated on the Bayer Didget Website, it subtly implies to parents that the health 
of their child is the company’s primary goal, and that financial reward is a secondary 
objective. Additionally, £5.00 from the sale of every Didget is donated to the Juvenile 
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Diabetes Research Foundation, demonstrating how committed Bayer is to the treatment 
and cure of this disease. 21 All of these elements have made the Didget more personable 
and therefore very favorable amongst parents engaged in online communities.  
The Bayer Didget has also received an enormous amount of attention because it is 
the first blood glucose meter designed specifically for children. Additionally, it is the first 
glucose monitor to incorporate testing, gaming and social media. Head of Bayer Medical 
Care, Sandra Peterson, has expressed her excitement over the Didget saying, “The Didget 
Meter is a revolutionary development in healthcare management. Up until now, blood 
glucose monitors have been created with adults in mind.”22 Bayer has recognized that the 
needs of children are very different to the needs of adults and should consequently be 
approached in light of this. The Didget allows children to manage their own health and 
communicate with others in similar situations, whilst also rewarding their efforts with 
pure fun.  John Gregory, Professor in pediatric endocrinology at Wales School of 
Medicine, Cardiff University, also commended Bayer for its efforts saying, “the Didget 
could ease the tension between parent and child that testing created by adding an element 
of fun and rewards to the routine…Because it is designed with children in mind, Bayer’s 
DIDGET meter can transform a child’s blood glucose testing experience from something 
they have to do into something they want to do.”23 The key word here is experience; 
Bayer has recognized that a positive testing experience is the catalyst for consistent 
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monitoring of blood glucose and should ultimately lead to the development of effective 
diabetes management. Bayer has achieved this experience by combining three separate 
experiences into one; testing and the light-hearted nature of gaming and social media.  
Echoing this sentiment and further praising Bayer is Kruse, who believes the 
following, “Designing and marketing an effective glucose reader is merely the first step; 
convincing a child to actually maintain a regular testing schedule is another.”19 Kruse 
recognizes that through the use of technology and marketing, Bayer has successfully 
provided consumers with a way to improve their lives with social media at the forefront. 
Furthermore, Kruse observes, “Far from the days of badgering young patients into paying 
even the most cursory attention to their readings, Bayer and Wessel count on kids being 
so engaged that they run the risk of over-testing. In fact, a maximum limit of readings per 
day is programmed into the game.”19 Ultimately, it is difficult to find fault with a 
company that strives to improve the lives of diabetic children.  
With regard to how successful the Bayer Didget has been, it is not yet possible to 
confirm how many Didgets have been sold, and thus, the number of children interacting 
on Bayer Didget World is unknown. However, it is possible to access the product’s 
success in terms of industry buzz, as well as the amount of attention the Didget has been 
awarded in both trade press and the blogosphere. Due to the nature of the product, it has 
received praise from the healthcare and marketing industries, as well as from the 
parenting community. What is evident from various online sources it that each of these 
markets is commending the Didget for different reasons, each specific to its own purpose 




Essentially, Bayer is offering children a way to improve their lives through the 
combined use of technology and most importantly, social media. To date, social media 
has, for the most part, proved to be nothing more than an appendage to advertising and 
consumer research in the pharmaceutical and healthcare industries. Most companies that 
have incorporated social media into their communication strategies have done so as an 
add-on. Enter the Bayer Didget. The Bayer Didget is the perfect example of social media 
actually being built into the marketing mix, as opposed to being an after-thought. 
Consumers are literally paying for social media as part of their treatment.  
Bayer has been recognized for their innovative approach in this area. Bob 
Gilbreath, author of Marketing with Meaning, a blog dedicated to marketing innovations, 
believes, “Anything that makes it easier – and even fun – for children to manage their 
diabetes is a huge opportunity to improve lives through marketing.”24  Gilbreath observes 
that there is an opportunity to integrate different elements of marketing with technology 
(and beyond) to create something that is more effective than the sum of its parts. 
Moreover, Gilbreath believes that social media should be part of the solution, not an 
accessory to it.  
From this it is evident that Bayer has achieved a great deal more than providing 
young diabetics with a fun way to manage their condition; it has molded a new healthcare 
approach, one that includes social media. Recognizing its own triumph, Bayer made an 
announcement to this effect on BAYNEWS, Bayer’s online news server, “Building on 40 
years of experience, the company is now transforming how kids engage in their diabetes 
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management.”22 Bayer is not the only company or person to have recognized this. Andre 
Blackman, a contributor to healthGAMERS, a blog dedicated to educating people about 
the possibilities of integrating health and gaming, states the following, “Innovation 
springs forth due to a need to connect and reinforce value – which is not always easy with 
kids. Kudos to you Bayer and Nintendo for getting this in the works.”25 The Bayer Didget 
has helped to position Bayer as a leader in innovation across several industries – 
healthcare, pharmaceuticals, marketing and gaming. Remaining cutting edge is vital in 
the pharmaceutical industry, as is creating buzz in social media, both of which Bayer has 
achieved. As a result, the Bayer Didget can only have a positive effect on Bayer’s brand 
image.  
In addition to this, Bayer has opened the door to the future, setting new standards 
in pharmaceutical marketing. Kevin Kruse, author of KruResearch, a blog dedicated to e-
patients and Health 2.0, believes that the Bayer Didget “offers a glimpse into the future of 
health devices that are mobile, social and drive motivation.”19 The idea of driving 
motivation is an important one. Bayer has not only motivated young diabetics to manage 
their condition more effectively, but continues to be a driving force behind motivating 
other companies to deliver more effective healthcare tools. Commenting further on the 
Bayer Didget is Gilbreath, “I would be interested to see the company commission and 
share research showing that this device is helping kids learn to test regularly. This could 
help drive other healthcare companies into a new way of encouraging education, testing, 
and treatment by making it more fun for children of all ages.”24 Bayer is proving to be a 
                                                
25 Blackman, Andre. "DIDGET: Nintendo and Diabetes Management." healthGAMERS. 
N.p., 23 July 2009. Web. 11 Nov. 2009.  
 
33 
driving force behind motivating people to better manage their health, as well as 
motivating pharmaceutical companies to provide people with tools to do so.  
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Building Blocks of a Successful Campaign 
 
Purpose & Goals 
 
Before a brand embarks on a social media marketing campaign, it must first 
determine the purpose of the campaign, as well as any specific objectives. The purpose 
may be product development, consumer service and support, or research, but a brand 
must establish this before it determines anything else. This will enable brands to map out 
the goals and objectives for the whole marketing strategy. Furthermore, a brand must be 
aware of what it wants from its consumers before engaging in dialogue with them. Chris 
Aarons, a contributor on i Media Connection, writes the following in his article “8 social 
media sins to avoid,” “It is important to fully consider your goals, objectives, and what 
your company is ready for before entering the social media space. This assessment will 
help you determine the right technologies, approaches and platforms to use based on your 
goals and ability to follow-through.”26  
Aarons also highlights the importance of a brand knowing its own capabilities; 
this will ensure that a brand does not set its expectations too high, and be doomed to 
failure before anything has even been launched. It will also encourage a brand to follow-
through on its long-term strategy. In order to do this, a brand should monitor social media 
marketing trends and online conversations to learn what it is that consumers are looking 
for with regards to pharmaceutical companies and their healthcare providers. Moreover, 
this will help brands meet consumer expectations. These efforts will also ensure that a 
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brand is not employing social media marketing as an add-on to its existing marketing 
strategy. To launch a truly successful social media campaign, it must come into fruition 
as a legitimate component of a brand’s strategy.  
Valuable Content 
 Once a brand has outlined its objectives and goals, it must then consider how it is 
going to achieve them. A brand must determine how it can be helpful, by either making 
consumers’ lives a little easier, or simply more interesting. A brand cannot expect 
consumers to congregate around its site unless there is useful and interesting content 
available that is specifically relevant to the audience a brand is seeking to reach. When 
considering this, Aarons suggests the following, “One way to ensure you avoid the 
pitfalls of operating social media in a silo is to ask yourself…how else can you leverage 
your social presence beyond just product launches and news events?”26 It is essential that 
the content put forward by a brand serves a purpose; a brand offering patient support 
must offer different content to a brand interested in product development. The Web site, 
blog or social networking site must also have a focus. Efforts must be based on one 
overarching concept, from which everything else can flow.  
Pharmaceutical companies should build their online communities around 
conditions, diseases, or more general healthcare topics, as opposed to building 
communities around branded products. The latter has a tendency to feel like an extension 
of traditional advertising, further marketing propaganda in the eyes of the consumer. If a 
consumer were to feel this was the case, they would be less likely to commit themselves 
to the community. Building communities around unbranded content is also beneficial as 
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it sends the message to consumers that the brand is more concerned with health and 
wellbeing than with selling products. Michael Maher, a contributor on Adotas, an 
interactive advertising blog, supports these views. In his article “Pharma Companies and 
Social Media Marketing,” Maher writes, “Focus on a disease state, not a specific product, 
which minimizes regulatory restrictions, and provides valuable learning’s for subsequent 
branded social marketing. Create disease education content (e.g., video) to establish 
greater corporate credibility and provide real value for patients.”3 Nonetheless, it is still 
important for brands to inform consumers as to who the creator or sponsor of the site 
actually is. This will ensure that the brand does not appear dishonest, as well as prevent 
consumers from feeling deceived. 
Further to this, the content provided must be exclusive and offer real insight. 
Pharmaceutical companies have a plethora of information at their disposal, and it is 
important for them to start leveraging this in new ways. Consumers pay healthcare 
providers large sums each year to gain insight into their health and wellbeing, often to 
little avail. Matt McGhee, a contributor on Small Business Search Marketing, offers 
similar advice in his article “12 Tips on Creating Content for Social Media,” “Your 
experience and expertise in your field will probably be of interest to others in your social 
community. This might be in the form of posts on your own blog, guest articles on other 
sites, how to videos, photo galleries…and more. Giving away your knowledge sets you 
up as an authority, earns respect, and helps you develop an audience.”27 Essentially, 
consumers must value the information being offered to them and believe that they would 
unable to access such information elsewhere. According to Blaise Nutter, a contributor on 
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i Media Connection, consumers will remain loyal to sites that offer them information they 
cannot access or find elsewhere. Additionally, Nutter states that the more a consumer 
likes a social media space, the more likely they are to contribute to its success, either by 
spreading the word or by offering information of their own.28 
Another important element of a brand’s social media space is presentation. A 
brand must ensure that its content is presented in the most aesthetically pleasing format. 
A brand’s social media space must reflect a brand’s image or values without appearing 
branded or too imposing. A brand must also take into account the specific needs of its 
audience. If the social media space is focused on a disease state or set of specific 
symptoms, then the brand must allow for this in the format of the site. The content must 
be clearly organized, and the site easy to navigate. If it is not, consumers will go in search 
of another space that encompasses such traits. Nutter reiterates this sentiment in his 
article, “They’re (consumers) looking for good content with as little time investment as 
possible.”28 With so many social networking sites and blogs available for different 
purposes, consumers have to split their time accordingly. Those that are costly in terms of 
time and energy are not going to be visited as often as those that are easy to manage.  
No matter what a brand chooses to include in its social media space, it must 
follow through on what it claims it will accomplish. This includes ensuring that the space 
serves the purpose outlined in the site’s introduction or “about” section. Additionally, this 
means not making empty promises to consumers or members of a brands online 
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community. This would only disappoint consumers, lowering their expectations of not 
only the site, but of the brand. 
Sharing & Building Relationships 
 The most important aspect of social media marketing is the building of 
relationships or connections. It is important for pharmaceutical companies to recognize 
that social media marketing is inherently different from one-directional advertising, like 
television and print. Establishing relationships should be the reason brands want to 
become involved in this medium. Poorly executed social media campaigns often 
resemble traditional advertising, packaged in a new way. Therefore, brands entering the 
world of social media marketing should be ready and willing to start a two-way dialogue 
with consumers. In his article, “8 social media sins to avoid,” Aarons explains this further 
by stating, “Remember it is called ‘social’ media and thus requires you to be genuinely 
social to get real results.”28 These brands should also be ready to share information with 
consumers, as opposed to feeding them propaganda about new products. A brand should 
be open to the opinions of its consumers, whether positive or negative.  
The ultimate goal is to build a community – one related to the pharmaceutical 
company’s values and research. Aarons highlights the importance of relationships for 
brands in online communities, saying, “Much like in romantic relationships, the benefit 
of creating legitimate relationships comes from the growth and connection you develop 
with your significant other, which, in this case, is your audience.”28 As with all 
relationships, trust takes time to build. Therefore, pharmaceutical companies should view 
their social media efforts as long-term strategy rather than sporadic stabs. By 
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implementing a long-term strategy, brands will be more equipped to grow their 
communities in size, and increase the depth of ongoing conversations.  
Furthermore, if a brand wants to build relationships and increase its online 
presence, it must provide the tools with which to do so. In order to decipher which tools 
would be relevant, a brand should refer back to its purpose and goals. If a brand is 
interested in product development then it should provide tools for consumers to vote or 
comment on content. Alternatively, if a brand is concerned with consumer service and 
support then it should incorporate tools that allow consumers to contact brand 
representatives at any given time, or ensure that feedback from queries is readily 
available.  
However, irrespective of purpose, a social media space should incorporate as 
many of the latest plug-ins as possible. In order to increase the user following of a social 
media space, the brand should employ plug-ins for the largest general market social 
networking sites, as well as for sites that are audience or content specific. In addition to 
this, brands should feature a blogroll in their social media space. A blogroll for related 
information is a useful tool for consumers and is also beneficial for brands; access to 
external sources indicates that a brand is more concerned with its consumer’s wellbeing 
and satisfaction, than with keeping them on its site.  
Be Social 
 Once brands have planned their online communities, they must consider the 
realities of how this will actually be achieved. With interesting content, insightful and 
meaningful dialogue should follow. It is vital that brands do not try and control 
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everything that is said in a social media space, as controlled conversation is neither social 
nor genuine. By keeping the channels of communication open, a level of trust will 
develop between pharmaceutical companies and consumers. Problems occur when brands 
are unable to lose control, and simply allow dialogue to take place unmediated. Of 
course, to some extent, it is necessary to steer the conversation in order to keep it on the 
right track. For the most part however, brands should resist the temptation to edit or 
sensor the dialogue. With regard to this, Aarons' states, “if someone’s going to say 
something bad about you, odds are they already are.”26 For this reason, it would be 
redundant for brands to try and censor all of the negative content on their sites. Moreover, 
it is important for brands to find a middle ground, where they are open to honest 
assessment, but yet have not ceded all control to consumers.  
 The fundamental point here is that it would be contradictory for pharmaceutical 
companies to be anti-social in this social sphere. Being truly engaged in social media 
means opening up to what consumers have to say about a brand or product, and engaging 
them in genuine conversation that is centered around the posted content.26 By embracing 
the social aspect of this medium, brands will be exposed to thoughts, feelings and stories 
about their brand, products or services that will yield invaluable insight.  
User Backlash & Plan B 
 Unfortunately, with regards to social media marketing, there is no guarantee for 
success. As with all popular media and marketing trends, social media is not immune to 
consumer backlash and burnout.28 Social media is however, easier to manage with regard 
to consumer backlash, as it enables brands to communicate directly with their consumers 
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in order to resurrect any problems. Nonetheless, when a brand allows dialogue to flow 
organically, it must accept the positive with the negative. The question is, what should a 
brand do when the negative begins to outweigh the positive, or when the number of users 
begins to dwindle? The definitive answer is that all brands participating in social media 
marketing must have a “Plan B.” 
“Plan B” should not be created when problems have already arisen, but should be 
part of the initial strategy. Anticipation is necessary in a fast pace environment such as 
social media. Inevitably, alterations may be needed, however. In terms of when a brand 
should implement its “Plan B” is at the discretion of the brand in question. This could be 
when a brand feels it has lost total control and the site no longer serves its purpose, or 
alternatively, when the content starts to damage the brand’s image. For instance, an 
intervention would be needed if a particular article sparked extremely negative feedback 
from consumers, which then appeared to continue unwarranted. In such a case, the brand 
would need to address the offending article and respond to the corresponding consumer 
feedback in an attempt to defuse the situation. The brand would then need to feature 
content that would guarantee positive feedback, in order to readjust the current tone of 
the site. Additionally, the brand should reveal a new interactive tool in order to 
temporarily distract users from the problem.  
Twitter 
Among the many social media superpowers is Twitter. Although still a relatively new 
platform, Twitter has demonstrated some unprecedented capabilities, which appear to be 
the reason for its huge success among consumers and businesses alike. According to 
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Nielson NetView, between February 2008 and February 2009, Twitter experienced a 
growth rate of 1382%, with the number of users increasing from 475, 000 to                    
7, 038, 000.29 Much of this growth can also be attributed to Twitter’s ability to cater to 
the needs of various consumer groups.  
Twitter is a very direct means of communication, one that allows brands to target 
specific messages to specific consumers. As a result, it has many implications for 
pharmaceutical companies and their social media marketing. Some of the possibilities for 
pharmaceutical brands include drug and device safety alerts; prescription management, 
such as pharmacy refill reminders; daily healthcare advice and tips; adherence and 
compliance messages; enhancing health-related support groups; round the clock disease 
management; and patient sharing.30  Moreover, according to John Mack, brands can 
utilize Twitter for almost any purpose, and pharmaceutical companies must endeavor to 
use their branded patient support twitter account for more than issuing safety alerts.30 
Further to this, Madhuri Shekar, a contributor on i media connection, has also 
observed Twitter’s enormous capabilities. In his article, “Twitter’s hidden marketing 
superpowers,” Shekar outlines three benefits for brands engaged with Twitter, and how 
these benefits can be achieved.31 Firstly, brands can drive sales through customer 
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engagement.31 By communicating openly with the consumer, brands can achieve a great 
deal; they can improve their image and reputation; create buzz; increase their consumer 
base; receive feedback on products; and most importantly, direct consumers to products 
and services.31 Secondly, a Twitter account can optimize a brand’s website or blog.31 By 
integrating a brands Twitter feed into its website, consumers are led to believe that the 
website is very active, influencing them to return more frequently. Thirdly, Twitter 
provides an effective platform for building referrals.31 Brands can employ word-of-mouth 
marketing, whereby consumers, or key influencers, are asked to “Tweet” about specific 
brands or products in a positive light. Additionally, brands can provide their key 
influencers with opportunities, discounts or other special deals related to the products or 
services, which would act as incentives. Essentially, there is potential for brands to build 
strong relationships with their consumer, and consequently, further increase their 
consumer base. 
Furthermore, Twitter offers numerous ways for marketers to monitor and analyze 
trends among Twitter users. For example, “Tweetscan” makes it possible for brands to 
see what consumers are saying – or “Tweeting” – about a particular topic, object or 
person, as well as who is saying it.32 Brands can use this feature to track the buzz of a 
new product on the market, or anticipate how a product will be received before it even 
enters the market.  
                                                
32 Senak, Mark. "The Increasing Utility of Twitter ." eye on fda. N.p., 9 Apr. 2009. Web. 








Additionally, this means that brands can pinpoint and track any early adopters and 
key influencers. The reason it is important for brands to do this is because Twitter has an 
innate viral effect, allowing one consumer to potentially reach thousands of other 
consumers. Therefore, if a brand is able to pinpoint the consumers who “Tweet” most 
frequently, or most favorably with regard to that specific brand, then it can target those 
consumers accordingly. Essentially, brands should be following topics and consumers of 
importance to them, and should be using this information to plan any future strategies.  
Integration & Mobility 
There has been a significant shift in consumer behavior within the last two years 
with regard to social media. Consumers have been quick to embrace mobile access in 
order to better manage and enhance their social media experience. Mobile adoption rates 
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have soared recently, with Facebook now boasting more than 65 million mobile 
subscribers.33 Furthermore, according to eMarketer, the number of mobile subscribers 
accessing social networks via a mobile device will grow from 243 million in 2009 to over 
800 million in 2012.34  James Briggs, a contributor on i media connection, explains why 
this is so significant in his article “Social minus mobile = fail;” he states, “there is 
growing evidence that social network users that access sites using their mobile phones are 
more engaged than those who do not.”34 Similarly, Facebook recently reported that 
people who use Facebook on their mobile devices are almost 50% more active on 
Facebook than non-mobile users.33 
  With the future of social media tied into mobile access, pharmaceutical 
companies must follow suit with consumers and embrace yet another social phenomenon. 
Integrating mobile functions into a brand’s social media space allows consumers to stay 
permanently connected, and communicate with ease throughout daily life. The 
immediacy of mobile access means that consumers can share real life experiences as they 
occur, while simultaneously receiving updates. There are also implications for consumers 
living with various medical conditions or for those who are simply health conscious. For 
example, with mobile applications, a person living with diabetes could potentially 
document their glucose readings and track them from any location. This would also allow 
consumers to stay connected to their source of support. Similarly, if a person begins to 
                                                
33 "Press Room." Facebook. N.p., 2009. Web. 11 Nov. 2009.  
 
34 Briggs, James. "Social minus mobile = fail." i Media Connection . N.p., 1 Sept. 2009. 




experience physical symptoms of some kind, they have the ability to access medical 
websites, or consult their support group.  
For brands, mobile access means the ability to stay permanently connected with 
consumers. This means that brands have the capability to share information with 
consumers at their convenience. It also allows brands to monitor the lives of consumers, 
observing their daily routines and behavior. Given this information, brands could better 
plan their marketing strategies. For example, a brand involved in diabetes care could 
track their patients’ daily behavior and suggest ways to improve it, or provide them with 
helpful tips to make daily life a little easier. Furthermore, a brand could develop their 
own mobile application, which could allow diabetics to track their daily progress, 
enabling them to better manage their health. With such an application, a brand could 
collaborate with leading pharmaceutical chains to facilitate a prescription service that 
would allow consumers to refill their prescriptions using their mobile device. An 
application such as this would help to build a relationship between brand and consumer, 
which could prevent consumers from switching pharmaceutical brands once a generic 
option became available. Again, fundamentally, mobile access allows consumers and 
brands to become more connected, with mutual benefits.  
Niche Social Networks 
Pharmaceutical companies aiming to target a more specific audience should 
consider niche social networking sites. These sites are incredibly important, as they have 
highly targeted audiences, who are particularly responsive to brands’ marketing 
messages.28 Larry Weintraub, CEO of Fanscape, believes that social networks are going 
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to become increasingly fragmented. In a recent interview, Weintraub commented on this 
trend, stating, “You’re going to see niche social networks, and then you’re going to see 
niche-niche social networks.”28 In light of this, and given the specialized nature of 
pharmaceutical marketing, niche social networks should be on every brand’s social media 
marketing agenda.  
There are currently hundreds of existing niche social networks for consumers 
living with specific illnesses, conditions and diseases. Many of these networks are for 
chronic conditions and diseases, such as diabetes, arthritis and cancer. For example, 
diabetics can join TuDiabetes – A community for People Touched By Diabetes; 
consumers who suffer from arthritis can join the Arthritis Foundation Forum; and cancer 
patients can join Know Cancer Community or CancerMatch. Furthermore, these social 
networks have the potential to provide brands with access to consumers that they could 
not otherwise reach, for example, online support groups for sufferers of social phobia, an 
anxiety disorder. With a condition such as this, a support group could only exist online, 





Fig. 9 - tudiabetes.org. Diabetes Hands Foundation, 2009. Web. 14 Nov. 2009.  
<http://tudiabetes.com/>. 
 
With regard to how brands should establish a presence in niche social media, 
there are two options to consider; joining and collaborating with an existing niche 
network, or creating a new one. By joining an existing network, brands would be able to 
eliminate a great deal of groundwork, as there would already be an active consumer base. 
This would allow the brand more time and money for developing creative strategies and 
new content. Furthermore, by collaborating with existing niche networks, a brand can 
make it appear as though it cares enough about the cause that it is willing to collaborate 
for the greater good. Alternatively, a brand can create its own niche network. This would 
allow a brand to tailor every component from scratch, giving the brand total control. 
However, brands must carefully consider the time and budgetary needs of creating a 
successful social network from scratch. Whether brands choose to join an existing niche 
social network, or build their own is irrelevant, however. The crucial point is that brands 
simply become involved in niche social networks. Also commenting on this trend is 
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Nutter, who states, “Odds are, if you can dream it, there’s an online network of people 
out there who are into it…somewhere out there, people are talking about your brand – 
and you’d better find them.”28 
Measuring Success 
When measuring social media, brands should group their efforts into three 
components; traffic, brand metrics, and return on investment. This will allow brands to 
view and track their efforts from multiple perspectives, providing an overview of their 
campaign’s success.  
 With regard to traffic, brands should examine three different aspects; the number 
of users, the quality of interaction among users, and the level of user retention.35 In terms 
of the number of users, brands should track page views, unique visitors, members, user 
posts, number of groups or forums, and contributors.36 Brands should also track the 
frequency of user visits to their social media sites. This should provide brands with some 
indication as to how invested their consumers are in their social media space.  
Similarly, it is vital that brands observe the quality of interaction among users, as 
a constructive and engaged user will contribute more to the social media site. When 
tracking this, brands should observe user generated content, referrals, completed profiles, 
user connections, reviews, and votes. Tracking the quality of interaction will also allow 
                                                
35 Lake, Chris. "10 ways to measure social media success." Econsultancy. N.p., 5 Mar. 
2009. Web. 11 Nov. 2009.  
 
36 "SOCIAL MEDIA METRICS." The Social Organization. N.p., n.d. Web. 11 Nov. 
2009.  




brands to assess users’ attitude and see how well their campaigns have been received. In 
turn, this will allow brands to track additional metrics. By observing consumer 
interaction, pharmaceutical companies can measure their brand awareness, attitude, 
recall, image, and favorability. Again, in turn, this should be an indication of brands’ 
ability to sustain a social media campaign long-term.  
In addition to traffic and quality of user interaction, brands should observe their 
rate of user retention. This is necessary because one of the key elements of social media 
is the building of long-term relationships. Therefore, the rate of retention should indicate 
how successful a brand has been in engaging with the consumer.  
 With regard to return on investment, brands should consider measuring three 
different components; marketing and sales, consumer support; and research and 
development. However, brands should not necessarily observe all three, but instead the 
ones that are relevant to their specific purpose and goals. When measuring marketing and 
sales, brands should take the following into consideration; number of sales leads; cost per 
number of sales leads; number of sales; time to qualified lead; mean revenue per 
consumer; and consumers’ lifetime value.36 In terms of consumer support, brands should 
observe the number of consumer queries, the rate of consumer satisfaction, and the cost 
of support per consumer. With regard to research and development, brands should 
observe the number of new ideas generated, the rate of idea fruition, as well as the 





Evolution, Not Revolution 
Pharmaceutical companies should expect their social media marketing efforts to 
be an evolutionary process, as opposed to a revolutionary one. By allowing a site to grow 
organically, consumers will feel less forced, and more led, into participating with the 
brand. Consumers will also feel that there is a less of an agenda on the part of the brand 
and as a result, will feel more open to genuine interaction. In light of this, brands should 
develop their social media spaces anticipating long-term growth. 
In order to better facilitate this evolutionary process, brands should continue to 
add new content and interactive features to their social media spaces at regular intervals. 
This will encourage consumers to return to the site frequently, and prevent them from 
growing bored with the content. If consumers are exposed to a lot of new content all at 
once, there is little for them to look forward to in the near future. Lisa Roner, a 
contributor on eye for pharma, reiterates this sentiment in her article, “Making e-
marketing more than just an add-on,” by saying, “It all comes down to long-term 
strategy, rather than quick wins… you want them to have a sense that if they unsubscribe, 
they might miss something important.”37 Additionally, users need time to become 
familiarized with a site’s various functions. By adding new features gradually, users have 
time to gain confidence with the site, making them more likely to return.  
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Creating a New Media Campaign: Vytorin 
Vytorin, a prescription drug, is used to treat the two sources of cholesterol. 
Produced by Merck/Schering-Plough Pharmaceuticals, Vytorin helps block the 
absorption of cholesterol from food, and reduces the cholesterol made naturally by the 
body.38 Although Vytorin was released in 2004, Merck has yet to establish an online 
presence for the drug beyond a one-dimensional website. Due to the chronic nature of 
cholesterol health, Vytorin provides Merck with an opportunity to expand into a range of 
social media. Using Vytorin as an example, the building blocks previously observed have 
been put into practice in order to demonstrate how an exemplary social media campaign 
could be developed.  
 




 Vytorin could build a social networking site for people suffering from high 
cholesterol. The purpose of this social networking site would be to assist those suffering 
                                                
38 "The 2 Sources of Cholesterol ." Vytorin. Merck/Schering-Plough Pharmaceuticals , 
2009. Web. 11 Nov. 2009.  
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from high cholesterol in the management of their cholesterol health. The initial primary 
objectives would be to build a community around this shared interest, and to gain insight 
into the lifestyles and practices of those suffering from high cholesterol. This insight 
would provide the brand with a base of information, which it could use to further develop 
the site and expand into other social media strategies. The brand could also use such 
information in product research and development.  
 The main focus of this site would be an online tracker and diary that would allow 
users to record their cholesterol levels, as well as goals. This tracker would also serve as a 
food diary and exercise log so that users could monitor their nutrition and fitness. The 
reason for this is that healthcare professionals have cited diet and exercise as the two 
primary ways for people to lower their cholesterol levels and manage their overall 
health.39 This combination would also allow users to observe any correlations between 
their nutrition, fitness and cholesterol levels. Additionally, the site would boast a built-in 
weight tracker. This would allow users to better manage their weight, and observe any 
correlation between this and their cholesterol levels.  
 Further to this, users would be able to earn bonus points with their online tracker. 
Points would be accredited to users when they report a decrease in poor cholesterol levels 
or weight. Points would also be accredited to users when they consistently log exercise 
and a healthy diet. Users would redeem their points for coupons towards Vytorin. This 
would help to discourage users from switching to the generic brand, Ezetimibe. Users 
who do not take Vytorin are however, under no obligation to redeem their points in this 
                                                
39 "Diet, Exercise, and VYTORIN." Vytorin. Merck/Schering-Plough Pharmaceuticals, 
2009. Web. 11 Nov. 2009.    
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way. The points system would serve as the only component on the site that is connected 
to the Vytorin brand. This would ensure that branding does not become an invasive force 
on the site, and allow users to enjoy the site without being disturbed by obvious 
marketing messages.  
 In addition to this, the site would incorporate a progress tracker in the form of a 
chart. The chart would plot users’ cholesterol levels and weight, as well as their relative 
goals. This would provide users with an overview of their own progress, encouraging 
them to stay focused and committed to their long-term goals. Further to this, the site 
should have a mobile device application for the tracking e-tools so that users can record 
their food intake and exercise throughout the day. This would mean that users could 
incorporate the site into their daily routine, further motivating them to remain on track.   
 The Home page for the site would feature specific topics related to cholesterol 
health. The featured topic or issue should be changed every two weeks in order to ensure 
that the site is providing users with fresh content. On this page, the brand should provide 
users with information and external resources pertaining to the chosen topic, as well as 
allow users to post relevant information or comment on content shared by others. Further 
to this, the Home page should incorporate a bi-weekly quiz that is tailored to the featured 
topic. This would encourage users to observe the site’s content carefully. Additionally, 
users would be able to earn bonus points by achieving high scores on the bi-weekly quiz.  
 In addition to the tracker and Home page, the site would incorporate numerous 
other elements. These would include Cholesterol 101, News, Nutrition, Fitness, My 
Meds, and My Doc. Cholesterol 101 would include basic information regarding 
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cholesterol, for example, what it is and how to control it. This component should also 
include a cholesterol tutorial in the form of a video. This would provide users with a 
more personal experience, making them more likely to remember the information.  
 With regard to the News component, the site should provide users with up-to-date 
information on all topics relevant to cholesterol health, and effective management of it. 
Essentially, this component would serve as a company blog where information could be 
presented in the form of broadcast news updates, human-interest stories, and interviews 
with healthcare specialists, or new research studies. Providing relevant and up-to-date 
information will further educate users, making them more accountable for their own 
health. Potentially, this would encourage users to take control, motivating them to 
become more proactive in the management on their cholesterol health.  
 With regard to the Nutrition component, the site would include both general and 
specific information. In terms of general content, the site would provide food and 
nutrition guidelines, pertaining to cholesterol health. This would include daily food 
recommendations and weight-loss advice. In terms of specific content, Nutrition would 
include a “how to” component, explaining how various foods should be prepared and 
cooked for optimum cholesterol health. This would be in the form of both text and 
videos. There would also be weekly food menus for users to follow to ensure that they do 
not grow bored with their diet and stray off course. Furthermore, this section of the site 
would feature “My Foods,” allowing users to upload their own menus, articles, advice, 
and cooking videos.  
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 Similarly, the Fitness section should comprise both brand-produced content, and 
user-generated content. The brand-produced content would outline exercise guidelines for 
various user demographics, as well as daily recommendations pertaining to various 
degrees of cholesterol health. This section would also provide instructional exercise 
videos, relevant to all levels of fitness. In terms of user-generated content, users would be 
able to contribute their own fitness advice, and comment on the shared content.  
 The Discussion section, in contrast, would be a completely user-generated 
component. However, the brand would still need to monitor all activity and intercept if 
needed. Here, users would be able to connect with others and discuss various topics, 
issues, products, or concerns they may have, relevant to the management of cholesterol 
health. The Discussion section should serve as a useful tool for Vytorin; the brand should 
be able to gather information from user discussions to use in the research and 
development of its product marketing. The brand should also be able to use this 
information to further develop and improve the site.  
 The last component of the site is My Doc, which would be used to provide users 
with information on how to effectively communicate with their doctors regarding 
cholesterol health. My Doc would include a list of questions users should ask their 
healthcare providers. Furthermore, My Doc would include a sub-section called My 
Doctor Diary. This application would allow users to log any future doctor appointments, 
as well as make notes about what was discussed at any relevant appointment. Potentially, 




 This study has demonstrated the growing need for social media marketing in the 
pharmaceutical industry. Social media usage among consumers is increasing rapidly and 
consumers expect brands to have a presence in this new social sphere. Similarly, as more 
brands begin to employ social media as part of their marketing strategy, brands that do 
not will be left behind. Much of the reason for this is that traditional media is unable to 
build consumer loyalty to the same extent as social media, when the latter is successfully 
crafted. Although there are obstacles facing pharmaceutical companies in terms of FDA 
laws and regulations and the use of social media marketing, brands must persevere, as 
they otherwise run the risk of losing consumers to generic brands.  
  As demonstrated, however, pharmaceutical companies cannot delve into social 
media marketing blindly. As with traditional media, social media can be executed poorly 
and thus, damage a brand’s image. Therefore, there are a range of elements that brands 
must take into consideration in order to achieve desired results. As discussed, these 
include a brand’s purpose and goals; social media content; how to build relationships 
with consumers; a brand’s sociability; handling user backlash; large and niche networks; 
integration and mobility of social media tools; and measuring progress and results. 
Although there is no formula for absolute success, these elements will ensure that brands 
have taken the necessary steps to achieve their goals.   
To date, the landscape of pharmaceutical marketing has been overrun by 
advertisements that feature slapstick comedy or clichéd stereotypes. Many of these 
marketing efforts appear to be out of date, and out of touch with consumers, which is 
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ironic given the innovative and somewhat visionary nature of the pharmaceutical 
industry. As these brands transition into direct-to-consumer marketing, they must also 
explore new ways to connect and engage with consumers. Social media could prove 



















Ebeling, Mary. "Beyond Advertising: The Pharmaceutical Industry's Hidden Marketing 
Tactics." PR Watch.org. N.p., 21 Feb. 2008. Web. 10 Nov. 2009.  
<http://www.prwatch.org/node/7026>. 
 
"Cone Finds that Americans Expect Companies to Have a Presence in Social Media." 
Editorial.Cone. N.p., 2009. Web. 10 Nov. 2009.  
<http://www.coneinc.com/content1182>. 
 
Maher, Michael. "Pharma Companies And Social Media Marketing." Editorial. adotas. 




Charlie Kimball. N.p., 7 July 2009. Web. 11 Nov. 2009.  
<http://www.charliekimball.com/news/kimball_novo_nordisk_twitter.php>. 
 
Mack, John. "Novo Nordisk Selectively Copies & Edits Kimball's Tweets." Pharma 




"charliekimball." Twitter. N.p., 2009. Web. 11 Nov. 2009.  
<http://twitter.com/charliekimball>. 
 
Racewithinsulin. Online posting. Twitter. Novo Nordisk, 2009. Web. 11 Nov. 2009.  
<http://twitter.com/racewithinsulin>. 
 
Monseau, Marc. "ABOUT JNJ BTW." JNJ BTW. N.p., 2009. Web. 10 Nov. 2009.  
<http://jnjbtw.com/about-jnj-btw/>. 
 
Senak, Mark. "J&J and Social Media - How'd They Do It? A Conversation with J&J." eye 




Lasica, JD. "Social media: opportunities for pharma." slideshare. N.p., Oct. 2009. Web. 
10 Nov. 2009.  
<http://www.slideshare.net/jdlasica/social-media-opportunities-for-pharma>. 
 
Ploof, Ron. Johnson & Johnson Does New Media: Lessons from a 123 year old, $64 
Billion New Media Innovator . N.p., 15 June 2009. Web. 10 Nov. 2009.  
<http://ronamok.com/ebooks/jnj_case_study.pdf>. 
 






Lee, Jaimy. "Sanofi-Aventis launches global video news site ." PR Week. N.p., 21 May 




statbrain. N.p., 2008. Web. 10 Nov. 2009.  
<http://www.statbrain.com/www.sanofi-aventis.tv/>.  
 




Shwen. "GSK Launches Corporate Blog and Sanofi Launches Sanofi-Aventis TV ."  




Ghinn, Daniel. "Sanofi-aventis.TV breathes life into pharmaceutical communications." 
Editorial. creation interactive. N.p., 17 July 2009. Web. 10 Nov. 2009.  
<http://creationinteractive.com/articles/sanofi-aventis-tv/>. 
 









"PRODUCT SUPPORT." Bayer Didget. Bayer HealthCare, 2009. Web. 10 Nov. 2009.  
<http://www.bayerdidget.co.uk/About-Didget/Product-Support>. 
 
"HOW TO BUY." Bayer Didget. Bayer HealthCare, 2009. Web. 11 Nov. 2009.  
      <http://www.bayerdidget.co.uk/How-to-Buy>. 
 
"First blood glucose designed especially for children ." BAYNEWS. Bayer, 28 Sept. 2009. 









Barr, Fiona. "Nintendo DS to offer diabetes care ." E-Health Insider. N.p., 22 July 2009. 




Gilbreath, Bob. "Bayer Creates Nintendo Game for Diabetes." marketing with meaning. 




Blackman, Andre. "DIDGET: Nintendo and Diabetes Management." healthGAMERS. 




Aarons, Chris. "8 social media sins to avoid." i Media Connection. N.p., 31 July 2009. 
Web. 11 Nov. 2009.  
<http://www.imediaconnection.com/content/23906.imc>. 
 
McGee, Matt. "12 Tips on Creating Content for Social Media." Small Business Search 
Marketing. N.p., 6 July 2008. Web. 11 Nov. 2009.  
<http://www.smallbusinesssem.com/creating-content-for-social-media/1207/>. 
 
Nutter, Blaise. "5 rules for marketing in niche social networks." i Media Connection. 
N.p., 31 Aug. 2009. Web. 11 Nov. 2009.  
<http://www.imediaconnection.com/content/24242.asp>. 
 
McCarthy, Caroline. "Nielsen: Twitter's growing really, really, really, really fast." cnet 
news. N.p., 19 Mar. 2009. Web. 11 Nov. 2009.  
<http://news.cnet.com/8301-13577_3-10200161-36.html>. 
 
Mack, John. "Twitter for Brands: Beyond Marketing." Pharma Marketing Blog. N.p., 28 




Shekar, Madhuri. "Twitter's hidden marketing superpowers." i Media Connection. N.p., 2 
Sept. 2009. Web. 11 Nov. 2009.  
<http://www.imediaconnection.com/content/24297.asp>. 
 
Senak, Mark. "The Increasing Utility of Twitter ." eye on fda. N.p., 9 Apr. 2009. Web. 11 
Nov. 2009.  






"Press Room." Facebook. N.p., 2009. Web. 11 Nov. 2009.  
<http://www.facebook.com/press/info.php?statistics>. 
 
Briggs, James. "Social minus mobile = fail." i Media Connection . N.p., 1 Sept. 2009. 
Web. 11 Nov. 2009.  
<http://www.imediaconnection.com/content/24280.asp>. 
 
Lake, Chris. "10 ways to measure social media success." Econsultancy. N.p., 5 Mar. 
2009. Web. 11 Nov. 2009.  
<http://econsultancy.com/blog/3407-10-ways-to-measure-social-media-success>. 
 
"SOCIAL MEDIA METRICS." The Social Organization. N.p., n.d. Web. 11 Nov. 2009.  
     <http://www.thesocialorganization.com/social-media-metrics.html>. 
 
Roner, Lisa. " Making e-marketing more than just an add-on." eye for pharma. N.p., 28 
July 2009. Web. 11 Nov. 2009.  
<http://social.eyeforpharma.com/story/making-e-marketing-more-just-add>. 
 
"The 2 Sources of Cholesterol ." Vytorin. Merck/Schering-Plough Pharmaceuticals , 




"Diet, Exercise, and VYTORIN." Vytorin. Merck/Schering-Plough Pharmaceuticals, 
2009. Web. 11 Nov. 2009.  
<http://www.vytorin.com/ezetimibe_simvastatin/vytorin/consumer/diet_exercise_


















Rhonda Nancy Taylor was born and raised in Hong Kong, where she attended South 
Island School. From 2004 to 2007 she attended the University of Manchester in the 
United Kingdom where she earned her Bachelor of Arts with Honors in American 
Studies. During the spring of 2006, she participated in a study abroad program at Arizona 
State University. Upon completion of her degree, she worked at a publishing company in 
Hong Kong for a year. In August 2008, she entered the Graduate School at The 
University of Texas at Austin.  
 
Contact information: Rhonda.taylor@mail.utexas.edu 
 
This professional report was typed by the author.  
 
 
 
 
 
 
